With respiratory infections increasing, an ongoing cost of living crisis and the Russia-Ukraine conflict, officials throughout Europe are beginning to look into contingency plans to deal with the concerning shortages of certain antibiotics.
The shortages seem to have most significantly hit the liquid formulations of the drugs usually used to treat children, such as amoxicillin, with officials calling this an “ongoing public health concern”. This issue has also impacted the US, with the FDA warning of similar shortages of the oral solution.
